During the quarter, we settled our worldwide patent litigation with Bruker on favorable terms and recognized an upfront ...
Revenue -- $1.9 billion reported for the quarter, compared to prior sales cycles impacted by earlier U.S. COVID-19 vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback